PSY62 - DIRECT COST OFFSETS RELATED TO BELIMUMAB SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN SPAIN
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2638
https://www.valueinhealthjournal.com/article/S1098-3015(18)35940-0/fulltext
Title :
PSY62 - DIRECT COST OFFSETS RELATED TO BELIMUMAB SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35940-0&doi=10.1016/j.jval.2018.09.2638
First page :
Section Title :
Open access? :
No
Section Order :
1988